Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aptuit Laurus was a joint venture combining Aptuit Inc.'s drug development expertise with Laurus Labs' R&D and manufacturing, focused on integrated services from discovery to commercial scale. It operated facilities in Hyderabad (160,000 sq ft R&D for 200+ scientists) and Visakhapatnam (34-acre manufacturing site with US FDA-validated blocks for general chemistry, oncology, and corticosteroids). Likely inactive post-2012 Laurus Labs majority acquisition (₹490M/~$8M USD equivalent). Current small scale (10-19 employees, $1-5M revenue) suggests legacy or diminished operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aptuit Laurus.